Evidence map›Paper›PMID 29567714›Full record

ArticleScience (New York, N.Y.)2018

Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice.

M Brown, F P Assen, A Leithner, J Abe, H Schachner, G Asfour, Z Bago-Horvath, J V Stein, P Uhrin, M Sixt and 1 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05754814 (SUper-Resolution Ultrasound Imaging of Erythrocytes), which is not on this map. Cited by 263 papers.

0numbers the graph read from it
0cells of the map it votes in
263citing papers in PubMed
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05754814 completednot on this mapstarted 2022, after this paper: background citation

SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes

TypeobservationalSponsorRigshospitalet, DenmarkRan2022 to 2026Enrolled20ConditionsHead and Neck Cancer, Lymphoma, Lymph Node MetastasisArmsMalignant lymph nodes
3 · Its place in the literature

Who cites it

263 citing papers in PubMed, 406 citations in OpenAlex.

  1. Trial
  2. Melanoma evolution in the lymph node shapes systemic outcomes.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Tumor-targeted IL2 promotes specific CD8Journal of experimental & clinical cancer research : CR · 2026
    Article
  11. Article
  12. Review
  13. Multicenter research: tumor microenvironment features combined with tumor cell characteristics predict lymph node metastasis in early gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

203 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

M BrownClinical Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-2876-8332
F P AssenInstitute of Science and Technology Austria (IST Austria), 3400 Klosterneuburg, Austria.
A LeithnerInstitute of Science and Technology Austria (IST Austria), 3400 Klosterneuburg, Austria.ORCID 0000-0002-1073-744X
J AbeTheodor Kocher Institute, University of Bern, 3012 Bern, Switzerland.ORCID 0000-0001-7511-4502
H SchachnerClinical Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7116-530X
G AsfourClinical Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-0641-6421
Z Bago-HorvathClinical Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
J V SteinTheodor Kocher Institute, University of Bern, 3012 Bern, Switzerland.
P UhrinInstitute of Vascular Biology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-9792-3420
M SixtInstitute of Science and Technology Austria (IST Austria), 3400 Klosterneuburg, Austria. dontscho.kerjaschki@meduniwien.ac.at michael.sixt@ist.ac.at.ORCID 0000-0002-6620-9179
D KerjaschkiClinical Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria. dontscho.kerjaschki@meduniwien.ac.at michael.sixt@ist.ac.at.ORCID 0000-0003-2155-0629
Medical University of Vienna · ATInstitute of Science and Technology Austria · ATUniversity of Bern · CH

Funding

European Research Council
6 · The paper itself

Abstract

During metastasis, malignant cells escape the primary tumor, intravasate lymphatic vessels, and reach draining sentinel lymph nodes before they colonize distant organs via the blood circulation. Although lymph node metastasis in cancer patients correlates with poor prognosis, evidence is lacking as to whether and how tumor cells enter the bloodstream via lymph nodes. To investigate this question, we delivered carcinoma cells into the lymph nodes of mice by microinfusing the cells into afferent lymphatic vessels. We found that tumor cells rapidly infiltrated the lymph node parenchyma, invaded blood vessels, and seeded lung metastases without involvement of the thoracic duct. These results suggest that the lymph node blood vessels can serve as an exit route for systemic dissemination of cancer cells in experimental mouse models. Whether this form of tumor cell spreading occurs in cancer patients remains to be determined.

Indexed as

Neoplasm SeedingAnimalsBlood VesselsCell Line, TumorFemaleHumansLungLymphatic MetastasisLymph NodesMammary Neoplasms, ExperimentalMiceNeoplasms, ExperimentalNeoplastic Cells, CirculatingThoracic Duct

Identifiers

PMID29567714
OpenAlexW2793277547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.